U.S. Structural Heart Imaging Market Is Slated To Witness Tremendous Growth In Future

 U.S. Structural Heart Imaging Market Summary

The U.S. structural heart imaging market size was estimated at USD 2.58 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2030. Market growth is fueled by the rising prevalence of structural heart diseases, an increasing geriatric population, and the growing adoption of minimally invasive procedures such as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Repair (TMVR). Technological advancements, including 3D/4D echocardiography, AI-powered diagnostics, and fusion imaging techniques, have enhanced both the accuracy and efficiency of diagnosis and treatment planning. Expanding hospital infrastructure, greater awareness of early disease detection, and collaborations between imaging companies and healthcare providers are further contributing to the sector’s momentum.

The expansion of structural heart imaging in the U.S. is primarily driven by the rising burden of cardiovascular and structural heart diseases, coupled with a growing emphasis on preventive healthcare. Conditions such as aortic stenosis, mitral regurgitation, and congenital heart defects are increasingly common, particularly among the elderly, who are more vulnerable to cardiac complications. Early detection and accurate diagnosis remain vital for timely intervention and improved patient outcomes, fueling the demand for advanced imaging solutions. Simultaneously, public awareness of preventive health checkups has increased significantly, with more individuals opting for routine screenings to identify cardiovascular issues before they progress to severe stages. This shift in patient behavior is strengthening the adoption of structural heart imaging technologies.

Key Market Trends & Insights

• Based on modality, the angiogram segment accounted for the largest market share of 36.4% in 2024. Its dominance is linked to its well-established role in diagnosing and assessing conditions such as coronary artery disease and congenital heart anomalies. The widespread adoption of angiograms in both routine diagnostics and interventional procedures underscores its continued relevance in clinical practice.
• The TAVR segment captured a 23.4% share of the market in 2024, highlighting its dominance within minimally invasive approaches. TAVR has gained prominence as a preferred treatment for aortic stenosis, particularly among elderly and high-risk patients who may not be suitable candidates for open-heart surgery. Its growing use demonstrates a broader trend toward safer, less invasive procedures that reduce recovery time and improve patient quality of life.
• Interventional cardiology held the largest share of more than 59.8% in 2024 and is expected to grow at the fastest CAGR during the forecast period. This growth is fueled by the rising incidence of cardiovascular and structural heart conditions requiring advanced interventional treatment strategies. The segment’s rapid expansion reflects the ongoing integration of imaging technologies into complex interventional procedures, enabling greater precision and improved patient outcomes.
• By end use, hospitals and clinics dominated the market with a share of nearly 54.5% in 2024. Their dominance stems from the availability of advanced diagnostic technologies, skilled healthcare professionals, and integrated patient care services. These facilities remain central to the adoption and implementation of cutting-edge imaging solutions.
• The ambulatory surgical centers (ASCs) segment, however, is projected to grow at the fastest CAGR of 6.80% during the forecast period. The growth of ASCs is attributed to the rising demand for cost-effective, efficient, and minimally invasive procedures in outpatient settings, which provide faster recovery and greater convenience for patients while reducing the burden on hospital systems.

Order a free sample PDF of the U.S. Structural Heart Imaging Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2.58 billion
• 2030 Projected Market Size: USD 3.64 billion
• CAGR (2025 - 2030): 5.9%

Key Companies & Market Share Insights

Major U.S. structural heart imaging players play an essential role in shaping market dynamics by actively striving to expand their market share and customer base. These leading companies are investing in research and development to innovate and launch new products that cater to the changing needs of healthcare providers and patients. Beyond innovation, they are also engaging in strategic initiatives such as partnerships, collaborations, mergers, and acquisitions. These efforts help enhance their product portfolios, strengthen their market presence, extend their reach, and tap into new customer segments, driving overall market growth.

Key Players

• Siemens Healthineers
• GE Healthcare
• Koninklijke Philips N.V.
• Canon Medical Systems
• Fujifilm Holdings Corporation
• Shanghai United Imaging Healthcare Co., LTD
• Abbott
• Terumo Corporation
• Samsung Medison Co., Ltd.
• Lepu Medical Technology

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. structural heart imaging market is positioned for sustained growth, supported by the rising prevalence of structural heart diseases, technological innovation, and the expanding adoption of minimally invasive interventions. Key segments such as angiograms, TAVR, and interventional cardiology continue to drive demand due to their critical role in diagnosis and treatment. Hospitals remain the largest end users, but ambulatory surgical centers are gaining momentum as outpatient care becomes more common. With greater awareness of preventive health, increasing collaborations among healthcare providers, and continuous advancements in imaging technology, the market is expected to expand steadily, offering promising opportunities for innovation and improved patient outcomes.